This anti-cancer function of RBM10 is implemented in part by blocking MDM2-mediated ubiquitination and degradation of p53 [134], though it has also been shown to suppress tumorigenesis by selectively modifying alternative splicing [32]. This evidence concerns the gene MDM2 and cancer.